Abbvie Inc’s recently made public that its EVP, CHIEF COMMERCIAL OFFICER Stewart Jeffrey Ryan unloaded Company’s shares for reported $12.36 million on Mar 31 ’25. In the deal valued at $210.08 per share,58,832 shares were sold. As a result of this transaction, Stewart Jeffrey Ryan now holds 53,234 shares worth roughly $9.83 million.
Then, Stewart Jeffrey Ryan bought 58,832 shares, generating $12,359,897 in total proceeds.
Before that, Reents Scott T sold 17,644 shares. Abbvie Inc shares valued at $3,746,527 were divested by the EVP, CHIEF FINANCIAL OFFICER at a price of $212.34 per share. As a result of the transaction, Reents Scott T now holds 11,577 shares, worth roughly $2.14 million.
Cantor Fitzgerald initiated its Abbvie Inc [ABBV] rating to an Overweight in a research note published on April 22, 2025; the price target was $210. Daiwa Securities also remained covering ABBV and has decreased its forecast on December 05, 2024 with a “Neutral” recommendation from previously “an Outperform” rating. Leerink Partners revised its rating on November 22, 2024. It rated ABBV as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of ABBV
On Friday, Abbvie Inc [NYSE:ABBV] saw its stock fall -0.53% to $184.60. Over the last five days, the stock has lost -6.99%. Abbvie Inc shares have risen nearly 3.88% since the year began. Nevertheless, the stocks have risen 13.57% over the past one year. While a 52-week high of $218.66 was reached on 03/10/25, a 52-week low of $153.58 was recorded on 04/09/25. SMA at 50 days reached $196.32, while 200 days put it at $189.28.
Levels Of Support And Resistance For ABBV Stock
The 24-hour chart illustrates a support level at 182.63, which if violated will result in even more drops to 180.66. On the upside, there is a resistance level at 188.17. A further resistance level may holdings at 191.74. The Relative Strength Index (RSI) on the 14-day chart is 45.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.88, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.23%. Stochastics %K at 56.32% indicates the stock is a holding.
The most recent change occurred on November 15, 2024 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $205 price target.
